{
  "XY4829_syn_1": "Indication: Centrally located NSCLC staging.\nProc: EBUS-TBNA.\nActions:\n- Sampled 2R, 4R, 4L, 7, 10R.\n- All stations PET+ and ROSE+.\nResult: Extensive N2/N3 disease.\nPlan: Molecular testing.",
  "XY4829_syn_2": "PROCEDURE NOTE: Endobronchial ultrasound (EBUS) was performed for staging of central NSCLC. A systematic evaluation revealed extensive mediastinal involvement. Transbronchial needle aspiration (TBNA) was performed at stations 2R, 4R, 4L, 7, and 10R. Rapid On-Site Evaluation (ROSE) confirmed malignancy in all sampled stations, indicating N3 disease. Molecular panels were requested.",
  "XY4829_syn_3": "Codes: 31653 (EBUS-TBNA 3+ stations).\nStations: 2R, 4R, 4L, 7, 10R.\nFindings: Malignancy confirmed in all 5 stations.\nNote: High complexity staging. Photodocumentation archived.",
  "XY4829_syn_4": "Procedure: EBUS Staging\nPatient: [REDACTED]\nSteps:\n1. Mod sedation.\n2. Systematic EBUS.\n3. Sampled 2R, 4R, 4L, 7, 10R.\n4. All came back positive on ROSE.\n5. Molecular sent from 4R/7.\nPlan: Oncology.",
  "XY4829_syn_5": "michael torres has central lung cancer. we did a full court press on the ebus. hit 2r 4r 4l 7 and 10r. everything was positive on rose. n3 disease basically everywhere. sent for molecular. patient stable.",
  "XY4829_syn_6": "Pt: [REDACTED]. CLINICAL: Staging centrally located NSCLC. EBUS-TBNA findings: Station 2R (PET+, ROSE+), Station 4R (PET+, ROSE+), Station 4L (PET+, ROSE+), Station 7 (PET+, ROSE+), Station 10R (PET+, ROSE+). IMPRESSION: Extensive N2/N3 disease confirmed. Molecular testing sent.",
  "XY4829_syn_7": "[Indication]\nCentrally located NSCLC.\n[Anesthesia]\nModerate.\n[Description]\nEBUS-TBNA of 5 stations: 2R, 4R, 4L, 7, 10R. All positive for malignancy. N3 disease confirmed.\n[Plan]\nMolecular characterization.",
  "XY4829_syn_8": "We performed an extensive staging EBUS on [REDACTED]. His cancer is centrally located, and unfortunately, we found spread to multiple lymph node stations. We sampled 2R, 4R, 4L, 7, and 10R, and every single one was positive for malignancy. This confirms N3 disease. We made sure to get enough tissue for genetic testing.",
  "XY4829_syn_9": "Procedure: Multi-station EBUS-TBNA.\nDiagnosis: Central NSCLC.\nSampling: Stations 2R, 4R, 4L, 7, 10R underwent aspiration.\nFindings: Cytological evidence of malignancy in all sampled nodes.\nOutcome: N3 stage verification.",
  "XY4829": "Pt: [REDACTED]\nMRN [REDACTED]\nDOB: [REDACTED]\n\nCLINICAL: Staging for centrally located NSCLC, extensive mediastinal involvement on imaging\n\nSedation approach: Moderate sedation, midazolam 4mg + fentanyl 100mcg\nRamsay score peaked at 3\nBP monitoring every 5 minutes, continuous pulse oximetry maintained >94%\n\nEBUS-TBNA findings:\nSystematic mediastinal evaluation performed.\n\nStation 2R: 11mm, 3 passes, PET+, ROSE+ for malignancy\nStation 4R: 15mm, 4 passes, PET+, ROSE+ for malignancy\nStation 4L: 12mm, 4 passes, PET+, ROSE+ for malignancy\nStation 7: 24mm, 5 passes, PET+, ROSE+ for malignancy\nStation 10R: 9mm, 3 passes, PET+, ROSE+ for malignancy\n\nAll nodes with adequate cellularity. Molecular testing panels sent from stations 4R and 7.\nComplete photodocumentation of accessible stations archived.\n\nNo procedural complications. Patient hemodynamically stable throughout.\n\nIMPRESSION: Extensive N2/N3 disease confirmed. Adequate tissue for complete molecular characterization obtained."
}
